Current ALS Research News
<h2><a href="/news/trial-tests-master-regulator-als">Trial Tests &#039;Master Regulator&#039; in ALS </a></h2>
<p>Genervon Biopharmaceuticals has launched a phase 2 trial to test its experimental drug GM604 in people with amyotrophic lateral sclerosis</p>
<span class="readmore"><a href="/news/trial-tests-master-regulator-als">Read More</a></span> <h2><a href="/news/melatonin-neuroprotective-als-mice">Melatonin is Neuroprotective in ALS Mice</a></h2>
<p>Treatment with the naturally occurring hormone delayed symptom onset, increased life span and inhibited nerve-cell loss in the SOD1 research mouse model of amyotrophic lateral sclerosis</p>
<span class="readmore"><a href="/news/melatonin-neuroprotective-als-mice">Read More</a></span> <h2><a href="/news/modifying-cellular-stress-response-way-treat-als">Modifying Cellular Stress Response as a Way To Treat ALS</a></h2>
<p>An MDA-supported research team has identified compounds that may prevent nerve-cell loss caused by dysregulation of a critical cell survival mechanism</p>
<span class="readmore"><a href="/news/modifying-cellular-stress-response-way-treat-als">Read More</a></span> <h2><a href="/news/mda-and-als-tdi-partnership-extended-through-2013">MDA and ALS TDI: Partnership Extended Through 2013</a></h2>
<p>A $3.2 million grant, awarded through MDA's Augie's Quest research initiative, will help support ALS research at the nonprofit biotech ALS Therapy Development Institute through 2013</p>
<span class="readmore"><a href="/news/mda-and-als-tdi-partnership-extended-through-2013">Read More</a></span> <h2><a href="/news/fda-approves-als-stem-cell-trial">FDA Approves ALS Stem Cell Trial </a></h2>
<p>Neuralstem will conduct a phase 2 dose-escalation and safety trial to test its ‘NSI-566’ neural stem cells in people with amyotrophic lateral sclerosis</p>
<span class="readmore"><a href="/news/fda-approves-als-stem-cell-trial">Read More</a></span>

Popular on Facebook

Research seeking therapies for ALS is advancing at a rapid pace, and there are more potential treatments in clinical trials than ever before. Here, we look at six drugs currently in clinical trials fo...
O.J. Brigance grew up in Houston dreaming of being a professional ball player, living the life of luxury and doing the only thing he’d ever want to do — play football. To no one’s surprise, he...
Put together the words amyotrophic lateral sclerosis (ALS) and the phrase clinical trials expert, and one name that is sure to follow is Merit Cudkowicz. Cudkowicz is chief of neurology and director...
Let’s face it. Frank Andrews is a trooper. The former civil engineer and avid scuba diver from Katy, Texas, has always loved the outdoors, going way back to his Eagle Scout days, growing up in the...
Don't Forget About ...
Consider these statistics: Four out of five businesses with over 100 employees have Twitter accounts. Sixty-one percent of consumers say they use social media to learn about products/features or...
When you have questions or need help, when you want to share tips and tricks or opinions, or when you just need to hear from someone who’s “been there,” one of the first places you can turn is an MDA...
Fight smart, not just hard. That’s the motto of Richard Bedlack, a world-renowned ALS research warrior who directs the ALS Clinic at Duke University, Durham, N.C. “Everyone I’ve ever met who is...

Advertisements

myMuscleTeam

Feedback Form
Feedback Analytics